Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF JULY 08, 2020 SAM #6796
SPECIAL NOTICE

65 -- Corona Virus Disease 2019 (COVID-19) Assays

Notice Date
7/6/2020 2:23:59 PM
 
Notice Type
Special Notice
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
NAVAL MEDICAL LOGISTICS COMMAND FORT DETRICK MD 21702-9203 USA
 
ZIP Code
21702-9203
 
Response Due
7/7/2020 7:00:00 AM
 
Archive Date
07/22/2020
 
Point of Contact
Lindsay K. Burdette, Phone: 3016198654
 
E-Mail Address
lindsay.k.burdette.civ@mail.mil
(lindsay.k.burdette.civ@mail.mil)
 
Description
NOTICE OF INTENT TO SOLE SOURCE Naval Medical Logistics Command (NMLC) intends to negotiate on a sole source basis (in accordance with FAR Part 13.106-1(b)(1) Soliciting from a single source). The proposed source is Hologic, Inc., 250 Campus Drive, Marlborough, MA 01752 (Cage Code 0UJ21). This requirement is for Corona Virus Disease 2019 (COVID-19) assays for multiple Naval Medical Treatment Facilities (MTFs), including but not limited to Naval Medical Center (NMC) Portsmouth, NMC San Diego, and Naval Hospital (NH) Jacksonville. The COVID-19 assays shall be capable of performing COVID-19 testing on Hologic�s base Panther system analyzers installed at Navy MTFs. The assays shall be compatible with the optimal throughput of the analyzer systems and shall not interfere with the optimum performance of the other immunoassay procedures performed on these instruments. The assays shall not impose additional maintenance, servicing, or calibration requirements for the optimum performance of the contractor�s reagent on the analyzer. Vendor shall be an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor or authorized reseller for the proposed equipment/system such that OEM warranty and service are provided and maintained by the OEM. All software licensing, warranty and service associated with the equipment/system shall be in accordance with the OEM terms and conditions. Prior to delivery, the assays shall have obtained Food and Drug Administration (FDA) Emergency Use Authorization (EUA). This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to submit a product meeting the minimum requirements specified above. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point.� All capability statements received by the due date of this notice will be considered by the Government.� A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response.� A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government.� Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement. Please note, a Justification and Approval will be posted within 14 days of award. Capability statements are due by 2:00 P.M. EST, 11 May 2020.� Capability statements shall be submitted by email ONLY as a Microsoft Word or Adobe PDF attachment to Lindsay Burdette, lindsay.k.burdette.civ@mail.mil. No phone calls will be accepted.
 
Web Link
SAM.gov Permalink
(https://beta.sam.gov/opp/7c61076ffaf848808479ec6d59554cee/view)
 
Place of Performance
Address: Frederick, MD 21702, USA
Zip Code: 21702
Country: USA
 
Record
SN05711781-F 20200708/200706230146 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.